Issue 37, 2022

Biotinylated magnetic molecularly imprinted polymer nanoparticles for cancer cell targeting and controlled drug delivery

Abstract

Here, multivalent functions have been successfully integrated on a single core–shell type nanostructure, for remote-controlled and receptor-targeted intracellular delivery of doxorubicin (DOX) to breast cancer cells that overexpress biotin receptors.

Graphical abstract: Biotinylated magnetic molecularly imprinted polymer nanoparticles for cancer cell targeting and controlled drug delivery

Supplementary files

Article information

Article type
Communication
Submitted
06 Feb 2022
Accepted
13 Apr 2022
First published
13 Apr 2022

Chem. Commun., 2022,58, 5642-5645

Biotinylated magnetic molecularly imprinted polymer nanoparticles for cancer cell targeting and controlled drug delivery

M. Nerantzaki, A. Michel, L. Petit, M. Garnier, C. Ménager and N. Griffete, Chem. Commun., 2022, 58, 5642 DOI: 10.1039/D2CC00740A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements